Indoxyl Sulfate (IS)-mediated Immune Dysfunction Provokes Endothelial Damage in Patients With End-Stage Renal Disease (ESRD)

Scientific Reports - United Kingdom
doi 10.1038/s41598-017-03130-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Thyroid Dysfunction in End Stage Renal Disease

Journal of Medical Science And Clinical Research
2017English

End Stage Renal Disease (ESRD) and the Marital Dyad

Social Science and Medicine
MedicinePhilosophy of ScienceHealthHistory
1982English

Incidence and Prevalence of Atrial Fibrillation (AF) in End Stage Renal Disease (ESRD) Patients

SM Journal of Nephrology and Therapeutics
2017English

Patient Reported Outcomes in End Stage Renal Disease (Esrd) AnemiaA Comprehensive Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cardiac Arrhythmias in Patients With End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review

American Journal of Internal Medicine
2019English

Association of Endothelin Genetic Variants and Hospitalized Infection Complications in End-Stage Renal Disease (ESRD) Patients

BMC Nephrology
Nephrology
2019English

Pericardial Effusion in Patients With End-Stage Renal Disease

Texas Heart Institute Journal
MedicineCardiovascular MedicineCardiology
2015English

The Perspective of End-Stage Renal Disease (ESRD) Patients Undergoing Peritoneal Dialysis (PD) Toward Self-Care: Integrative ReviewThe Perspective of End-Stage Renal Disease (ESRD) Patients Undergoing Peritoneal Dialysis (PD) Toward Self-Care: Integrative

The Bangkok Medical Journal
2018English

Pulmonary Hypertension in Patients With End-Stage Renal Disease

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy